Literature DB >> 26505802

Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?

Stefanie Weigel1, Hans W Hense1, Jan Heidrich1, Shoma Berkemeyer1, Walter Heindel1, Oliver Heidinger1.   

Abstract

PURPOSE: To investigate the association between age at screening and detection rates for ductal carcinoma in situ (DCIS) separately for different nuclear grades after introduction of a population-based digital mammography screening program.
MATERIALS AND METHODS: The retrospective study was approved by the ethics board and did not require informed consent. In 733 905 women aged 50-69 years who participated in a screening program for the first time in 2005-2008 (baseline examinations were performed with digital mammography), DCIS detection rates were determined for 5-year age groups (detection rates per 1000 women screened) to distinguish high-, intermediate-, and low-grade DCIS. Multivariable logistic regression was used to compare detection rates between age groups by adjusting for screening units (P < .05).
RESULTS: There were 989 graded DCIS diagnoses among 733 905 women (detection rate, 1.35‰): 419 diagnoses of high-grade DCIS (detection rate, 0.57‰), 388 diagnoses of intermediate-grade DCIS (detection rate, 0.53‰), and 182 diagnoses of low-grade DCIS (detection rate, 0.25‰). Detection rate for types of DCIS combined increased significantly across age groups (50-54 years, detection rate of 1.15‰ [254 of 220 985 women]; 55-59 years, detection rate of 1.23‰ [218 of 177 782 women]; 60-64 years, detection rate of 1.34‰ [201 of 150 415 women]; and 65-69 years, detection rate of 1.71‰ [316 of 184 723 women]; P < .001). Of note, the detection rate for high-grade DCIS showed a significant increase with age (odds ratio, 1.18 per 5-year age group; P < .0001). The increase was lower for intermediate-grade DCIS (odds ratio, 1.11; P = .016) and not significant for low-grade DCIS (P = .10).
CONCLUSION: Total DCIS detection rates increase with age, mostly because of an increase in high- and intermediate-grade DCIS, which are precursor lesions that carry a higher risk for transition to more aggressive invasive breast cancer than low-grade DCIS.

Entities:  

Mesh:

Year:  2015        PMID: 26505802     DOI: 10.1148/radiol.2015150322

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  [Diagnosis of breast diseases in a certified breast center].

Authors:  Markus Müller-Schimpfle; Nicole Herröder; Petra Hödl
Journal:  Radiologe       Date:  2021-01-06       Impact factor: 0.635

2.  An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma in situ Within Fibroadenoma.

Authors:  Ashley Marumoto; Susan Steinemann; Nancy Furumoto; Stacey Woodruff
Journal:  Hawaii J Med Public Health       Date:  2019-02

3.  Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.

Authors:  Si Eun Lee; Ha Yan Kim; Jung Hyun Yoon; Eun-Kyung Kim; Jee Ye Kim; Min Jung Kim; Ga Ram Kim; Youngjean Vivian Park; Hee Jung Moon
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

4.  The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.

Authors:  P A van Luijt; E A M Heijnsdijk; J Fracheboud; L I H Overbeek; M J M Broeders; J Wesseling; G J den Heeten; H J de Koning
Journal:  Breast Cancer Res       Date:  2016-05-10       Impact factor: 6.466

5.  Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy.

Authors:  Andrea J Clark; Howard R Petty
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

6.  The importance of early detection of calcifications associated with breast cancer in screening.

Authors:  J J Mordang; A Gubern-Mérida; A Bria; F Tortorella; R M Mann; M J M Broeders; G J den Heeten; N Karssemeijer
Journal:  Breast Cancer Res Treat       Date:  2017-10-17       Impact factor: 4.872

7.  Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.

Authors:  Ryan Nipp; Angela C Tramontano; Chung Yin Kong; Pari Pandharipande; Emily C Dowling; Deborah Schrag; Chin Hur
Journal:  Cancer Med       Date:  2018-01-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.